Cost –effectiveness analysis 3L of axicabtagene ciloleucel vs tisagenlecleucel and lisocabtagene maraleucel in Japan

Future Oncology, Ahead of Print.

Source: Future Oncology - April 10, 2024 Category: Cancer & Oncology Authors: Saaya Tsutsu é Shinichi Makita Hiroya Asou Hiroyuki Matsuda Reiko Yamaura Todd D Taylor Source Type: research